000153 丰原药业
午间休市 05-20 11:30:00
资讯
新帖
简况
丰原药业（000153）披露2025年度业绩说明会安排，5月18日股价下跌1.13%
证券之星 · 05-18 18:46
丰原药业（000153）披露2025年度业绩说明会安排，5月18日股价下跌1.13%
每周股票复盘：丰原药业（000153）全资子公司获富马酸伏诺拉生原料药批文
证券之星 · 05-17
每周股票复盘：丰原药业（000153）全资子公司获富马酸伏诺拉生原料药批文
丰原药业（000153）披露全资子公司获得富马酸伏诺拉生化学原料药上市申请批准通知书，5月13日股价上涨0.16%
证券之星 · 05-13
丰原药业（000153）披露全资子公司获得富马酸伏诺拉生化学原料药上市申请批准通知书，5月13日股价上涨0.16%
丰原药业(000153.SZ)子公司获得富马酸伏诺拉生化学原料药上市申请批准通知书
智通财经 · 05-12
丰原药业(000153.SZ)子公司获得富马酸伏诺拉生化学原料药上市申请批准通知书
每周股票复盘：丰原药业（000153）获新药注册证书
证券之星 · 05-10
每周股票复盘：丰原药业（000153）获新药注册证书
每周股票复盘：丰原药业（000153）2025年净利降38.19%
证券之星 · 05-02
每周股票复盘：丰原药业（000153）2025年净利降38.19%
股市必读：丰原药业一季报 - 第一季度单季净利润同比下降2.67%
证券之星 · 04-30
股市必读：丰原药业一季报 - 第一季度单季净利润同比下降2.67%
图解丰原药业一季报：第一季度单季净利润同比下降2.67%
证券之星 · 04-29
图解丰原药业一季报：第一季度单季净利润同比下降2.67%
股市必读：丰原药业（000153）3月23日收盘跌6.53%，主力净流入277.86万元
证券之星 · 03-24
股市必读：丰原药业（000153）3月23日收盘跌6.53%，主力净流入277.86万元
每周股票复盘：丰原药业（000153）获复方醋酸钠林格注射液注册证
证券之星 · 03-08
每周股票复盘：丰原药业（000153）获复方醋酸钠林格注射液注册证
丰原药业(000153.SZ)取得复方醋酸钠林格注射液药品注册证
智通财经 · 03-03
丰原药业(000153.SZ)取得复方醋酸钠林格注射液药品注册证
股市必读：丰原药业（000153）2月6日董秘有最新回复
证券之星 · 02-09
股市必读：丰原药业（000153）2月6日董秘有最新回复
丰原药业：本公司代工生产丸红制药醋酸来法莫林注射用稀释液产品
证券之星 · 02-06
丰原药业：本公司代工生产丸红制药醋酸来法莫林注射用稀释液产品
每周股票复盘：丰原药业（000153）子公司补缴税款1656万影响当期损益
证券之星 · 02-01
每周股票复盘：丰原药业（000153）子公司补缴税款1656万影响当期损益
丰原药业（000153）披露全资子公司补缴税款及滞纳金合计1656.09万元公告，1月29日股价下跌0.3%
证券之星 · 01-29
丰原药业（000153）披露全资子公司补缴税款及滞纳金合计1656.09万元公告，1月29日股价下跌0.3%
丰原药业：已完成向弘丰基金增资事项
证券之星 · 01-20
丰原药业：已完成向弘丰基金增资事项
每周股票复盘：丰原药业（000153）回购注销88,200股
证券之星 · 01-11
每周股票复盘：丰原药业（000153）回购注销88,200股
丰原药业（000153）披露回购注销部分限制性股票完成暨股本变动的公告，1月9日股价上涨0.46%
证券之星 · 01-09
丰原药业（000153）披露回购注销部分限制性股票完成暨股本变动的公告，1月9日股价上涨0.46%
每周股票复盘：丰原药业（000153）拟增资5300万元参与基金
证券之星 · 01-02
每周股票复盘：丰原药业（000153）拟增资5300万元参与基金
丰原药业最新公告：拟向合肥弘丰股权投资基金中心增资5300万元
证券之星 · 2025-12-29
丰原药业最新公告：拟向合肥弘丰股权投资基金中心增资5300万元
加载更多
公司概况
公司名称：
安徽丰原药业股份有限公司
所属行业：
医药制造业
上市日期：
2000-09-20
主营业务：
安徽丰原药业股份有限公司的主营业务是医药制造和商业流通。公司的主要产品是大容量注射剂（大输液）、粉针类、小容量注射剂、散剂、片剂、胶囊剂、颗粒剂、贴剂、原料药。公司被评为安徽省智能工厂、安徽省创新型产品。
发行价格：
18.80
{"stockData":{"symbol":"000153","market":"SZ","secType":"STK","nameCN":"丰原药业","latestPrice":6.08,"timestamp":1779250818000,"preClose":6.19,"halted":0,"volume":2733640,"delay":0,"changeRate":-0.0178,"floatShares":459000000,"shares":465000000,"eps":0.2118,"marketStatus":"午间休市","change":-0.11,"latestTime":"05-20 11:30:00","open":6.18,"high":6.18,"low":6.06,"amount":16674900,"amplitude":0.0194,"askPrice":6.08,"askSize":114,"bidPrice":6.06,"bidSize":1440,"shortable":0,"etf":0,"ttmEps":0.2118,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779253200000},"marketStatusCode":3,"adr":0,"adjPreClose":6.19,"symbolType":"stock","openAndCloseTimeList":[[1779240600000,1779247800000],[1779253200000,1779260400000]],"highLimit":6.81,"lowLimit":5.57,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":464685522,"isCdr":false,"pbRate":1.32,"roa":"--","peRate":28.706327,"roe":"1.74%","epsLYR":0.2139,"committee":0.405002,"marketValue":2825000000,"turnoverRate":0.006,"status":1,"floatMarketCap":2790000000},"requestUrl":"/m/hq/s/000153","defaultTab":"news","newsList":[{"id":"2636014022","title":"丰原药业（000153）披露2025年度业绩说明会安排，5月18日股价下跌1.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636014022","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636014022?lang=zh_cn&edition=full","pubTime":"2026-05-18 18:46","pubTimestamp":1779101176,"startTime":"0","endTime":"0","summary":"截至2026年5月18日收盘，丰原药业报收于6.13元，较前一交易日下跌1.13%，最新总市值为28.49亿元。该股当日开盘6.25元，最高6.25元，最低6.04元，成交额达4690.52万元，换手率为1.68%。近日，丰原药业发布《关于召开2025年度业绩说明会的公告》。公告显示，公司已于2026年4月29日在巨潮资讯网披露《公司2025年年度报告》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800029923.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000153","BK0239","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636640100","title":"每周股票复盘：丰原药业（000153）全资子公司获富马酸伏诺拉生原料药批文","url":"https://stock-news.laohu8.com/highlight/detail?id=2636640100","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636640100?lang=zh_cn&edition=full","pubTime":"2026-05-17 03:53","pubTimestamp":1778961188,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，丰原药业报收于6.2元，较上周的6.45元下跌3.88%。本周，丰原药业5月11日盘中最高价报6.49元。本周关注点来自公司公告汇总：全资子公司获富马酸伏诺拉生化学原料药上市申请批准公司公告汇总安徽丰原药业股份有限公司全资子公司蚌埠丰原涂山制药有限公司收到国家药品监督管理局核准签发的富马酸伏诺拉生《化学原料药上市申请批准通知书》，该原料药符合药品注册有关要求，批准注册。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051700001220.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000153","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635785350","title":"丰原药业（000153）披露全资子公司获得富马酸伏诺拉生化学原料药上市申请批准通知书，5月13日股价上涨0.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635785350","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635785350?lang=zh_cn&edition=full","pubTime":"2026-05-13 18:36","pubTimestamp":1778668593,"startTime":"0","endTime":"0","summary":"截至2026年5月13日收盘，丰原药业报收于6.37元，较前一交易日上涨0.16%，最新总市值为29.6亿元。丰原药业于近日披露公告，公司全资子公司蚌埠丰原涂山制药有限公司收到国家药品监督管理局核准签发的富马酸伏诺拉生《化学原料药上市申请批准通知书》，该原料药符合药品注册有关要求，批准注册。富马酸伏诺拉生为钾离子竞争性酸阻滞剂，用于反流性食管炎和幽门螺杆菌感染治疗。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300034788.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000153","BK0239","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634941692","title":"丰原药业(000153.SZ)子公司获得富马酸伏诺拉生化学原料药上市申请批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2634941692","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634941692?lang=zh_cn&edition=full","pubTime":"2026-05-12 17:28","pubTimestamp":1778578101,"startTime":"0","endTime":"0","summary":"智通财经APP讯，丰原药业(000153.SZ)发布公告，近日，公司全资子公司蚌埠丰原涂山制药有限公司收到国家药品监督管理局核准签发的富马酸伏诺拉生《化学原料药上市申请批准通知书》。富马酸伏诺拉生是一种钾离子竞争性酸阻滞剂(简称P-CAB)，可以抑制胃酸的生成和抑制胃肠道上部粘膜损伤，主要用于反流性食管炎和幽门螺杆菌感染的治疗。上述富马酸伏诺拉生《化学原料药上市申请批准通知书》的获得，将丰富公司产品线，优化公司产品结构，有利于提升公司的市场竞争力，对公司未来的发展将产生积极的影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1440727.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0060","BK0239","000153","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634412554","title":"每周股票复盘：丰原药业（000153）获新药注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2634412554","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634412554?lang=zh_cn&edition=full","pubTime":"2026-05-10 03:14","pubTimestamp":1778354053,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，丰原药业报收于6.45元，较上周的6.45元上涨0.0%。本周，丰原药业5月6日盘中最高价报6.56元。丰原药业当前最新总市值29.97亿元，在化学制药板块市值排名137/150，在两市A股市值排名4703/5200。上市许可持有人和生产企业均为蚌埠丰原涂山制药有限公司。该药品适用于1岁至11岁儿童慢性便秘，以及5岁至11岁儿童粪便嵌塞的治疗。此次药品注册证书的获得将丰富公司产品线，提升市场竞争力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051000001276.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","000153","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632964049","title":"每周股票复盘：丰原药业（000153）2025年净利降38.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632964049","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632964049?lang=zh_cn&edition=full","pubTime":"2026-05-02 04:56","pubTimestamp":1777668969,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，丰原药业报收于6.45元，较上周的6.32元上涨2.06%。本周关注点来自业绩披露要点：丰原药业2025年归母净利润9941.59万元，同比下降38.19%。股本股东变化股东户数变动截至2026年3月31日，公司股东户数为3.45万户，较2025年12月31日减少1571.0户，减幅4.36%；户均持股由1.29万股增至1.35万股，户均持股市值为8.84万元。截至2026年3月31日，占用资金本金已全部收回并收到利息，未造成经济损失。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200002888.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000153","BK0239","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631241735","title":"股市必读：丰原药业一季报 - 第一季度单季净利润同比下降2.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631241735","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631241735?lang=zh_cn&edition=full","pubTime":"2026-04-30 05:11","pubTimestamp":1777497073,"startTime":"0","endTime":"0","summary":"股本股东变化股东户数变动近日丰原药业披露，截至2026年3月31日公司股东户数为3.45万户，较12月31日减少1571.0户，减幅为4.36%。业绩披露要点财务报告丰原药业2026年一季报显示，一季度公司主营收入8.36亿元，同比下降11.14%；归母净利润3700.68万元，同比下降2.67%；扣非净利润3116.07万元，同比下降7.06%；负债率58.98%，财务费用566.01万元，毛利率22.9%。现金分红总额预计为46,468,552.20元，占归属于上市公司股东净利润的46.74%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000016112.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000153"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631369155","title":"图解丰原药业一季报：第一季度单季净利润同比下降2.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631369155","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631369155?lang=zh_cn&edition=full","pubTime":"2026-04-29 04:32","pubTimestamp":1777408362,"startTime":"0","endTime":"0","summary":"证券之星消息，丰原药业2026年一季报显示，一季度公司主营收入8.36亿元，同比下降11.14%；归母净利润3700.68万元，同比下降2.67%；扣非净利润3116.07万元，同比下降7.06%；负债率58.98%，财务费用566.01万元，毛利率22.9%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900009725.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000153"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621704081","title":"股市必读：丰原药业（000153）3月23日收盘跌6.53%，主力净流入277.86万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621704081","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621704081?lang=zh_cn&edition=full","pubTime":"2026-03-24 04:04","pubTimestamp":1774296258,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘，丰原药业报收于5.87元，下跌6.53%，换手率2.67%，成交量12.24万手，成交额7354.33万元。当日关注点来自交易信息汇总：丰原药业3月23日收盘报5.87元，跌6.53%，当日成交1224.5万元，该股已连续3日下跌。来自交易信息汇总：3月23日主力资金净流入277.86万元，结束前10个交易日主力资金累计净流出态势。董秘最新回复投资者： 请问丰原药业去年的年度净利润是多少？","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400004668.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000153","BK0060","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617879663","title":"每周股票复盘：丰原药业（000153）获复方醋酸钠林格注射液注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2617879663","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617879663?lang=zh_cn&edition=full","pubTime":"2026-03-08 02:57","pubTimestamp":1772909827,"startTime":"0","endTime":"0","summary":"截至2026年3月6日收盘，丰原药业报收于6.71元，较上周的6.77元下跌0.89%。本周关注点公司公告汇总：丰原药业获复方醋酸钠林格注射液药品注册证书。公司公告汇总安徽丰原药业股份有限公司近日收到国家药品监督管理局核准签发的复方醋酸钠林格注射液和复方醋酸钠林格注射液的《药品注册证书》，药品注册分类为化学药品3类，有效期均为12个月，上市许可持有人和生产企业均为安徽丰原药业股份有限公司。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030800000990.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000153","BK0060","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616495348","title":"丰原药业(000153.SZ)取得复方醋酸钠林格注射液药品注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2616495348","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616495348?lang=zh_cn&edition=full","pubTime":"2026-03-03 17:31","pubTimestamp":1772530278,"startTime":"0","endTime":"0","summary":"智通财经APP讯，丰原药业(000153.SZ)公告，公司收到国家药品监督管理局核准签发的复方醋酸钠林格注射液(250ml)《药品注册证书》及复方醋酸钠林格注射液(500ml)《药品注册证书》。复方醋酸钠林格注射液适用于循环血量及组织间液减少时的细胞外液的补充，代谢性酸中毒的纠正。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1409504.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","000153","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610577987","title":"股市必读：丰原药业（000153）2月6日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2610577987","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610577987?lang=zh_cn&edition=full","pubTime":"2026-02-09 02:00","pubTimestamp":1770573644,"startTime":"0","endTime":"0","summary":"截至2026年2月6日收盘，丰原药业报收于6.68元，上涨0.6%，换手率1.87%，成交量8.56万手，成交额5734.38万元。根据合作协议，本公司代工生产丸红制药醋酸来法莫林注射用稀释液产品，丸红制药负责代工产品的销售覆盖和客户维护，本公司负责生产。当日关注点来自交易信息汇总：2月6日主力资金净流入63.62万元，显示主力对丰原药业短期走势持相对积极态度。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020900000962.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000153","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609557291","title":"丰原药业：本公司代工生产丸红制药醋酸来法莫林注射用稀释液产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2609557291","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609557291?lang=zh_cn&edition=full","pubTime":"2026-02-06 15:30","pubTimestamp":1770363028,"startTime":"0","endTime":"0","summary":"根据合作协议，本公司代工生产丸红制药醋酸来法莫林注射用稀释液产品，丸红制药负责代工产品的销售覆盖和客户维护，本公司负责生产。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020600020485.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","01477","000153","BK1574","BK0239","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608077209","title":"每周股票复盘：丰原药业（000153）子公司补缴税款1656万影响当期损益","url":"https://stock-news.laohu8.com/highlight/detail?id=2608077209","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608077209?lang=zh_cn&edition=full","pubTime":"2026-02-01 03:24","pubTimestamp":1769887452,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，丰原药业报收于6.58元，较上周的6.66元下跌1.2%。本周，丰原药业1月26日盘中最高价报6.73元。本周关注点公司公告汇总：全资子公司补缴税款及滞纳金合计1,656.09万元，计入2025年当期损益 公司公告汇总安徽丰原药业股份有限公司全资子公司蚌埠丰原涂山制药有限公司依据国家税收法律法规开展自查，应补缴税款及滞纳金合计1,656.09万元，其中税款1,122.77万元，滞纳金533.32万元。本次补缴不影响公司正常经营。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020100001140.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000153","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607780039","title":"丰原药业（000153）披露全资子公司补缴税款及滞纳金合计1656.09万元公告，1月29日股价下跌0.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607780039","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607780039?lang=zh_cn&edition=full","pubTime":"2026-01-29 23:24","pubTimestamp":1769700256,"startTime":"0","endTime":"0","summary":"截至2026年1月29日收盘，丰原药业报收于6.54元，较前一交易日下跌0.3%，最新总市值为30.39亿元。该股当日开盘6.53元，最高6.6元，最低6.48元，成交额达4906.04万元，换手率为1.63%。近日，丰原药业发布《关于公司补缴税款的公告》。公告显示，公司全资子公司蚌埠丰原涂山制药有限公司依据国家税收法律法规开展自查，应补缴税款及滞纳金合计1,656.09万元，其中税款1,122.77万元，滞纳金533.32万元。截至公告披露日，相关款项已全部缴纳。本次补缴不影响公司正常经营。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900044519.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000153","BK0239","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604193198","title":"丰原药业：已完成向弘丰基金增资事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2604193198","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604193198?lang=zh_cn&edition=full","pubTime":"2026-01-20 16:15","pubTimestamp":1768896912,"startTime":"0","endTime":"0","summary":"证券之星消息，丰原药业(000153)01月20日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，公司公告称向弘丰基金增资5300万元，整体增资1.2亿元，请问增资资金是否已经到位？根据披露，弘丰基金成立至今并未投资什么项目，此次突然增资是否有了投资意向标的？丰原药业回复：您好，截至目前公司已完成向弘丰基金增资事项。弘丰基金的后续情况，公司将按规定履行相应的信息披露义务。感谢关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012000022130.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","000153","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602369175","title":"每周股票复盘：丰原药业（000153）回购注销88,200股","url":"https://stock-news.laohu8.com/highlight/detail?id=2602369175","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602369175?lang=zh_cn&edition=full","pubTime":"2026-01-11 03:58","pubTimestamp":1768075088,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，丰原药业报收于6.49元，较上周的6.27元上涨3.51%。本周，丰原药业1月9日盘中最高价报6.5元。1月5日盘中最低价报6.3元。丰原药业当前最新总市值30.16亿元，在化学制药板块市值排名136/150，在两市A股市值排名4613/5182。本周关注点公司公告汇总：丰原药业回购注销88,200股限制性股票，占总股本0.0190%。注销后公司总股本由464,773,722股减至464,685,522股，变更于2026年1月9日在中登公司深圳分公司完成。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011100001272.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000153","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602372326","title":"丰原药业（000153）披露回购注销部分限制性股票完成暨股本变动的公告，1月9日股价上涨0.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602372326","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602372326?lang=zh_cn&edition=full","pubTime":"2026-01-09 22:44","pubTimestamp":1767969849,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，丰原药业报收于6.49元，较前一交易日上涨0.46%，最新总市值为30.16亿元。该股当日开盘6.45元，最高6.5元，最低6.42元，成交额达4640.74万元，换手率为1.56%。公司近日发布公告称，安徽丰原药业股份有限公司已完成回购注销3名激励对象持有的88,200股限制性股票，占总股本的0.0190%，回购价格为2.67元/股，支付回购款246,091.23元。本次回购注销完成后，公司总股本由464,773,722股减少至464,685,522股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010900041329.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","000153","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2600803995","title":"每周股票复盘：丰原药业（000153）拟增资5300万元参与基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2600803995","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600803995?lang=zh_cn&edition=full","pubTime":"2026-01-02 04:06","pubTimestamp":1767297973,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，丰原药业报收于6.41元，较上周的6.55元下跌2.14%。本周，丰原药业12月22日盘中最高价报6.55元。丰原药业当前最新总市值29.14亿元，在化学制药板块市值排名135/150，在两市A股市值排名4594/5181。公司拟以自有资金向该基金增资5,300万元人民币，出资总额由15,000万元增至20,300万元，占基金总认缴出资额的47.21%。该事项已获公司董事会审议通过，不构成关联交易或重大资产重组。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010200001212.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000153","BK0060","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595789293","title":"丰原药业最新公告：拟向合肥弘丰股权投资基金中心增资5300万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2595789293","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595789293?lang=zh_cn&edition=full","pubTime":"2025-12-29 18:10","pubTimestamp":1767003035,"startTime":"0","endTime":"0","summary":"丰原药业(000153.SZ)公告称，公司拟以自有资金向合肥弘丰股权投资基金中心（有限合伙）增资5300万元人民币。该事项已经公司第十届四次（临时）董事会会议审议通过。增资后，丰原药业认缴出资额为20300万元，占比47.21%。本次增资不影响公司正常的经营活动，对公司当期和未来财务状况和经营成果不存在重大影响。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122900025522.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","000153","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1779250878498,"stockEarnings":[{"period":"1week","weight":-0.0267},{"period":"1month","weight":-0.0578},{"period":"3month","weight":-0.055},{"period":"6month","weight":-0.0884},{"period":"1year","weight":0.0453},{"period":"ytd","weight":-0.0128}],"compareEarnings":[{"period":"1week","weight":-0.0107},{"period":"1month","weight":0.0292},{"period":"3month","weight":0.0214},{"period":"6month","weight":0.0607},{"period":"1year","weight":0.2381},{"period":"ytd","weight":0.0506}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"安徽丰原药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"34467人(较上一季度减少4.36%)","perCapita":"13313股","listingDate":"2000-09-20","address":"安徽省芜湖市无为市通江大道188号","registeredCapital":"46468万元","survey":" 安徽丰原药业股份有限公司的主营业务是医药制造和商业流通。公司的主要产品是大容量注射剂（大输液）、粉针类、小容量注射剂、散剂、片剂、胶囊剂、颗粒剂、贴剂、原料药。公司被评为安徽省智能工厂、安徽省创新型产品。","listedPrice":18.8},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"丰原药业(000153)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供丰原药业(000153)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"丰原药业,000153,丰原药业股票,丰原药业股票老虎,丰原药业股票老虎国际,丰原药业行情,丰原药业股票行情,丰原药业股价,丰原药业股市,丰原药业股票价格,丰原药业股票交易,丰原药业股票购买,丰原药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"丰原药业(000153)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供丰原药业(000153)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}